November 27, 2017
AZ submits NDA to Japan’s authorities for Tagrisso
AstraZeneca on Monday announced the submission of a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals and Medical Devices Agency for the…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 27, 2017
The Hometown Pharmacy picks Digital Pharmacist
Digital Pharmacist has been selected by The Hometown Pharmacy to offer integrated digital solutions to its independent pharmacy customers.
November 24, 2017
Premaitha signs new partner to offer NIPT solution in East Asia
Premaitha Health has signed an agreement with a new laboratory partner to offer an NIPT screening solution in a new East Asian territory for Premaitha.
November 22, 2017
Midatech updates its Bilbao factory
Midatech Pharma , the international specialty pharmaceutical company focused on developing and commercialising products in oncology, has received formal notification from…
November 22, 2017
FDA approves Juluca, allowing virologically suppressed HIV patients to reduce the number of antiretrovirals
ViiV Healthcare, a HIV specialist company (majority) owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, on Wednesday…
November 21, 2017
Symcel secures €3.572 million
Symcel has secured €3.572 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against…
November 20, 2017
Oxford Pharmascience step closer to MAA in sweden for OXPzero Ibuprofen containing OTC
Oxford Pharmascience has received scientific advice from the MPA (Swedish regulatory authority) about the development programme for future marketing authorisation…
November 20, 2017
EC approves Novartis’s Tasigna
The European Commission (EC) has approved Novartis’s Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic…
November 16, 2017
Pneumonia in babies, prevention
Pneumonia represents a significant health risk in the very young and very old, and mortality rates remain high among the…
November 15, 2017
FDA OK’s AstraZeneca’s breast cancer drug
US Food and Drug Administration (FDA) has approved a new indication for AstraZeneca’s Faslodex(fulvestrant), expanding the indication to include use with…